Testing effectiveness (Phase 2)Looking for participantsNCT05783323
What this trial is testing
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13